Relationship between ecstasy use and depression: A study controlling for poly-drug use

Psychopharmacology

Volumn 173, Issue 3-4, 2004, Pages 411-417

  Roiser, Jonathan P ^a   Sahakian, Barbara J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

3,4 Methylenedioxymethamphetamine (MDMA); Affective Go No go; Beck Depression Inventory (BDI); Depression; Ecstasy; Poly drug use

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ADULT; ARTICLE; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MOOD; MOOD DISORDER; MULTIPLE DRUG ABUSE; PRIORITY JOURNAL; SELF REPORT; SUBSTANCE ABUSE; TASK PERFORMANCE;

ADULT; ATTENTION; BIAS (EPIDEMIOLOGY); DEPRESSION; EMOTIONS; FEMALE; HUMANS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; SEROTONIN AGENTS; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 2542533733     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1705-6     Document Type: Article

References (33)

1. Beck AT, Ward CH, Medelson M, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561-571
2. Bremner JD, Innis RB, Salomon RM, Staib LH, Ng CK, Miller HL, Bronen RA, Krystal JH, Duncan J, Rich D, Price LH, Malison R, Dey H, Soufer R, Charney DS (1997) Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Arch Gen Psychiatry 54:364-374
3. Carr-Hill RA, Rice N, Roland M (1996) Socioeconomic determinants of rates of consultation in general practice based on fourth national morbidity survey of general practices. BMJ 312:1008-1012
4. Curran HV, Travill RA (1997) Mood and cognitive effects of ±3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): week-end "high" followed by mid-week low. Addiction 92:821-831
5. Drevets WC, Price JL, Simpson JR Jr, Todd RD, Reich T, Vannier M, Raichle ME (1997) Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386:824-827
6. Elliott R, Rubinsztein JS, Sahakian BJ, Dolan RJ (2000) Selective attention to emotional stimuli in a verbal go/no-go task: an fMRI study. Neuroreport 11:1739-1744
7. Elliott R, Rubinsztein JS, Sahakian BJ, Dolan RJ (2002) The neural basis of mood-congruent processing biases in depression. Arch Gen Psychiatry 59:597-604
8. Gamma A, Buck A, Berthold T, Vollenweider FX (2001) No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: a [H2(15)O]-positron emission tomography study. J Clin Psychopharmacol 21:66-71
9. Gerra G, Zaimovic A, Ferri M, Zambelli U, Timpano M, Neri E, Marzocchi GF, Delsignore R, Brambilla F (2000) Long-lasting effects of (±)3,4-methylene-dioxymethamphetamine (ecstasy) on serotonin system function in humans. Biol Psychiatry 47:127-136
10. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62
11. Hatzidimitriou G, McCann UD, Ricaurte GA (1999) Altered serotonin innervation patterns in the forebrain of monkeys treated with (±)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. J Neurosci 19:5096-5107
12. Kish SJ, Furukawa Y, Ang L, Vorce SP, Kalasinsky KS (2000) Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user. Neurology 55:294-296
13. Maclnnes N, Handley SL, Harding GF (2001) Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms. J Psychopharmacol 15:181-186
14. Matt GE, Vazquez C, Campbell WK (1992) Mood-congruent recall of affectively toned stimuli - a meta-analytic review. Clin Psychol Rev 12:227-255
15. Mayberg HS, Liotti M, Brannan SK, McGinnis S, Mahurin RK, Jerabek PA, Silva JA, Tekell JL, Martin CC, Lancaster JL, Fox PT (1999) Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 156:675-682
16. McKenna DJ, Peroutka SJ (1990) Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). J Neurochem 54:14-22
17. McLean A, Rubinsztein JS, Robbins TW, Sahakian BJ (2003) The effects of tyrosine depletion in normal healthy volunteers: implications for unipolar depression. Psychopharmacology (in press)
18. Morgan MJ, McFie L, Fleetwood H, Robinson JA (2002) Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence? Psychopharmacology 159:294-303
19. Murphy FC, Sahakian BJ, Rubinsztein JS, Michael A, Rogers RD, Robbins TW, Paykel ES (1999) Emotional bias and inhibitory control processes in mania and depression. Psychol Med 29:1307-1321
20. Murphy FC, Smith KA, Cowen PJ, Robbins TW, Sahakian BJ (2002) The effects of tryptophan depletion on cognitive and affective processing in healthy volunteers. Psychopharmacology 163:42-53
21. Parrott AC, Lasky J (1998) Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance. Psychopharmacology 139:261-268
22. Parrott AC, Sisk E, Turner JJ (2000) Psychobiological problems in heavy "ecstasy" (MDMA) polydrug users. Drug Alcohol Depend 60:105-110
23. Parrott AC, Milani RM, Parmar R, Turner JD (2001) Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems. Psychopharmacology 159:77-82
24. Parrott AC, Buchanan T, Scholey AB, Heffernan T, Ling J, Rodgers J (2002) Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users. Hum Psychopharmacol 17:309-312
25. Reneman L, Booij J, de Bruin K, Reitsma JB, de Wolff FA, Gunning WB, den Heeten GJ, van den Brink W (2001) Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet 358:1864-1869
26. Ricaurte GA, Finnegan KF, Nichols DE, DeLanney LE, Irwin I, Langston JW (1987) 3,4-Methylenedioxyethylamphetamine (MDE), a novel analogue of MDMA, produces long-lasting depletion of serotonin in the rat brain. Eur J Pharmacol 137:265-268
27. Rubinzstein JS, Rogers RD, Riedel WJ, Mehta MA, Robbins TW, Sahakian BJ (2001) Acute dietary tryptophan depletion impairs maintenance of "affective set" and delayed visual recognition in healthy volunteers. Psychopharmacology 154:319-326
28. Semple DM, Ebmeier KP, Glabus MF, O'Carroll RE, Johnstone EC (1999) Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ("ecstasy") users. Br J Psychiatry 175:63-69
29. Smith KA, Morris JS, Friston KJ, Cowen PJ, Dolan RJ (1999) Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletion. Br J Psychiatry 174:525-529
30. Tavares JV, Drevets WC, Sahakian BJ (2003) Cognition in mania and depression. Psychol Med 33:959-967
31. Thomasius R, Petersen K, Buchert R, Andresen B, Zapletalova P, Wartberg L, Nebeling B, Schmoldt A (2003) Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users. Psychopharmacology 167:85-96
32. Verheyden SL, Hadfield J, Calin T, Curran HV (2002) Sub-acute effects of MDMA (±3,4-methylenedioxymethamphetamine, "ecstasy") on mood: evidence of gender differences. Psychopharmacology 161:23-31
33. Verkes RJ, Gijsman HJ, Pieters MS, Schoemaker RC, de Visser S, Kuijpers M, Pennings EJ, de Bruin D, Van de Wijngaart G, Van Gerven JM, Cohen AF (2001) Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology 153:196-202